Literature DB >> 16802324

Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex.

Xiaocheng Wu1, Vilma Cokkinides, Vivien W Chen, Marion Nadel, Yuan Ren, Jim Martin, Gary L Ellison.   

Abstract

BACKGROUND: This study examined associations of subsite-specific colorectal cancer incidence rates and stage of the disease with county-level poverty.
METHODS: The 1998-2001 colorectal cancer incidence data, covering 75% of the United States population, were from 38 states and metropolitan areas. The county-level poverty data were categorized into 3 groups according to the percentage of the population below the poverty level in 1999: <10% (low-poverty), 10%-19% (middle-poverty), and >or=20% (high-poverty). Age-adjusted subsite-specific incidence rates (for all ages) and stage-specific incidence rates (for ages >or=50) were examined by race (whites and blacks), sex, and the county's poverty level. The differences in the incidence rates were examined using the 2-tailed z-statistic.
RESULTS: The incidence rates of proximal colon cancer were higher among white males (11% higher) and white females (15% higher) in the low-poverty than in the high-poverty counties. No differences across county poverty levels were observed among whites for distal colon and rectal cancers or among blacks for all the subsites. The late-to-early stage incidence rate ratios were higher in the high-poverty than in the low-poverty counties among white and black males for distal colon and rectal cancers, among white females for distal colon cancer, and among black females for rectal cancer. For proximal colon cancer, however, the late-to-early stage rate ratios were similar across all county poverty levels.
CONCLUSIONS: Higher incidence rates of proximal cancer were observed among white males and females in the low-poverty counties relative to the high-poverty counties. The higher late-to-early stage rate ratios in high-poverty than in low-poverty counties is observed for distal colon and rectal cancers, but not for proximal colon cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16802324     DOI: 10.1002/cncr.22009

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.

Authors:  Nancy N Baxter; Joan L Warren; Michael J Barrett; Therese A Stukel; V Paul Doria-Rose
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

Review 2.  Occupational exposures and colorectal cancers: a quantitative overview of epidemiological evidence.

Authors:  Enrico Oddone; Carlo Modonesi; Gemma Gatta
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study.

Authors:  Xian-Feng Lin; Ke-Qing Shi; Jie You; Wen-Yue Liu; Ying-Wan Luo; Fa-Ling Wu; Yong-Ping Chen; Danny Ka-Ho Wong; Man-Fung Yuen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

4.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

5.  Is proliferative colonic disease presentation changing?

Authors:  Vito D Corleto; Cristiano Pagnini; Maria Sofia Cattaruzza; Ermira Zykaj; Emilio Di Giulio; Giovanna Margagnoni; Emanuela Pilozzi; Giancarlo D'Ambra; Antonietta Lamazza; Enrico Fiori; Mario Ferri; Luigi Masoni; Vincenzo Ziparo; Bruno Annibale; Gianfranco Delle Fave
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

6.  Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.

Authors:  John Virostko; Anna Capasso; Thomas E Yankeelov; Boone Goodgame
Journal:  Cancer       Date:  2019-07-22       Impact factor: 6.860

7.  Neighborhood disadvantage and racial disparities in colorectal cancer incidence: a population-based study in Louisiana.

Authors:  Denise M Danos; Tekeda F Ferguson; Neal R Simonsen; Claudia Leonardi; Qingzhao Yu; Xiao-Cheng Wu; Richard A Scribner
Journal:  Ann Epidemiol       Date:  2018-03-22       Impact factor: 3.797

8.  Colorectal cancer in alaska native people, 2005-2009.

Authors:  Janet J Kelly; Steven R Alberts; Frank Sacco; Anne P Lanier
Journal:  Gastrointest Cancer Res       Date:  2012-09

9.  A 50-year review of colorectal cancer in African Americans: implications for prevention and treatment.

Authors:  Hassan Ashktorab; Mehdi Nouraie; Fatemeh Hosseinkhah; Edward Lee; Charles Rotimi; Duane Smoot
Journal:  Dig Dis Sci       Date:  2009-06-25       Impact factor: 3.199

Review 10.  Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.

Authors:  Glenn E Palomaki; Linda A Bradley; Michael P Douglas; Katherine Kolor; W David Dotson
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.